Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Stand... oleh Tamara Díaz-Redondo, Tamara Díaz-Redondo, Rocio Lavado-Valenzuela, Rocio Lavado-Valenzuela, Begoña Jimenez, Begoña Jimenez, Tomas Pascual, Fernando Gálvez, Alejandro Falcón, Maria del Carmen Alamo, Cristina Morales, Marta Amerigo, Javier Pascual, Alfonso Sanchez-Muñoz, Alfonso Sanchez-Muñoz, Macarena González-Guerrero, Luis Vicioso, Luis Vicioso, Aurora Laborda, Maria Victoria Ortega, Maria Victoria Ortega, Lidia Perez, Lidia Perez, Aranzazu Fernandez-Martinez, Nuria Chic, Jose Manuel Jerez, Jose Manuel Jerez, Martina Alvarez, Martina Alvarez, Martina Alvarez, Aleix Prat, Nuria Ribelles, Nuria Ribelles, Emilio Alba, Emilio Alba, Emilio Alba